References
- Fernández L, Galán Y, Jiménez R, et al. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba. International Journal of Epidemiology. 2005; 34((1)):: 193–97.
- Schubotz D, Rolston B, Simpson A. Sexual behaviour of young people in Northern Ireland: first sexual experience. Critical Public Health. 2004; 14: (2): 177–90.
- Antoine C, Liebens F, Carly B, et al. Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women’s Health Initiative trial. Human Reproduction. 2004; 19(3): 741–56.
- Fisher B, Jeong J-H, Bryant J, et al. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet. 2004; 364: 858–68.
- Pansegrau GK, Gelmon KA. Lymph-node-negative oestrogen-receptor-positive breast cancer [Comment]. Lancet. 2004; 364: 820–21.
- Jurdi R, Khawaja M. Caesarean section rates in the Arab region: a cross-national study. Health Policy and Planning. 2004; 9(2): 101–10.
- Andrist LC, Arias RD, Nucatola D, et al. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004; 70: 359–63.
- Hannestad YS, Lie RT, Rortveit G, et al. Familial risk of urinary incontinence in women: population based cross sectional study. BMJ. 2004; 329: 889–91.
- Teather D. Merck’s cervical cancer drug successful. Guardian (UK). 7 October 2005.